Bent Laursen Ejlertsen

Bent Laursen Ejlertsen

Clinical Professor

Member of:

  • Clinical Oncology


  1. 2024
  2. Published

    Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients

    Woolpert, K. M., Schmidt, J. A., Ahern, T. P., Hjorth, C. F., Farkas, D. K., Ejlertsen, Bent Laursen, Collin, L. J., Lash, T. L. & Cronin-Fenton, D. P., 2024, In: Breast cancer research : BCR. 26, 1, 11 p., 59.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer

    Berg, T., Jensen, M. B., Rossing, Caroline Maria, Bechmann, T., Donskov, F., Knoop, A. S. & Ejlertsen, Bent Laursen, 2024, In: JAMA network open. 7, 3, 9 p., e242174.

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Incidence and survival of primary metastatic breast cancer in Denmark: implication of breast cancer screening, classification, and staging practice

    Berg, T., Jensen, M. B., Rossing, Caroline Maria, Axelsen, C. T., Kümler, Iben, Søndergaard, L., Vogsen, M., Knoop, A. S. & Ejlertsen, Bent Laursen, 2024, In: Acta oncologica (Stockholm, Sweden). 63, p. 277-287 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Molecular subtyping improves breast cancer diagnosis in the Copenhagen Breast Cancer Genomics Study

    Berg, T., Jensen, M. B., Celik, A., Talman, M. L., Misiakou, M. A., Knoop, A. S., Nielsen, Finn Cilius, Ejlertsen, Bent Laursen & Rossing, Caroline Maria, 2024, In: JCI insight. 9, 7, 13 p., e178114.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Prognostic Value of Pretreatment Plasma C-Reactive Protein in Patients with Early-Stage Breast Cancer

    Andersen, H. H., Bojesen, Stig Egil, Johansen, Julia Sidenius, Ejlertsen, Bent Laursen, Berg, T., Tuxen, M., Madsen, K., Danø, H., Flyger, H., Jensen, M. B. & Nielsen, Dorte Lisbet, 2024, In: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 33, 5, p. 662-670 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. 2023
  8. Published

    The impact of single nucleotide polymorphisms on return-to-work after taxane-based chemotherapy in breast cancer

    Hjorth, C. F., Damkier, P., Stage, T. B., Feddersen, S., Hamilton-Dutoit, S., Ejlertsen, Bent Laursen, Lash, T. L., Bøggild, H., Sørensen, H. T. & Cronin-Fenton, D., Feb 2023, In: Cancer Chemotherapy and Pharmacology. 91, 2, p. 157-165 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Multigene profiles to guide the use of neoadjuvant chemotherapy for breast cancer: a Copenhagen Breast Cancer Genomics Study

    Jensen, M., Pedersen, C. B., Misiakou, M., Talman, M. L. M., Gibson, L., Tange, U. B., Kledal, H., Vejborg, I., Kroman, Niels Thorndahl, Nielsen, Finn Cilius, Ejlertsen, Bent Laursen & Rossing, M., 2023, In: npj Breast Cancer. 9, 8 p., 47.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial

    for the ExteNET Study Group, F. T. E. S. G., 2023, In: European Journal of Cancer. 184, p. 48-59 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

    Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis

    Depner, J. F., Berg, T., Ejlertsen, Bent Laursen, Andreasen, L. W., Møller, S. & Maraldo, M. V., 2023, In: Acta oncologica (Stockholm, Sweden). 62, 11, p. 1502-1510 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  12. 2022
  13. Published

    The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis

    Pedersen, R. N., Esen, B. O., Mellemkjaer, L., Christiansen, P., Ejlertsen, Bent Laursen, Lash, T. L., Norgaard, M. & Cronin-Fenton, D., 8 Mar 2022, In: National Cancer Institute. Journal (Online). 114, 3, p. 391-399 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  14. Published

    A catalog of curated breast cancer genes

    Bose, M., Benada, Jan, Thatte, Jayashree Vijay, Kinalis, S., Ejlertsen, Bent Laursen, Nielsen, Finn Cilius, Sørensen, Claus Storgaard & Rossing, Caroline Maria, 2022, In: Breast Cancer Research and Treatment. 191, p. 431-441

    Research output: Contribution to journalJournal articleResearchpeer-review

  15. Published

    Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials

    Bradley, R., Braybrooke, J., Gray, R., Hills, R. K., Liu, Z., Pan, H., Peto, R., Dodwell, D., McGale, P., Taylor, C., Francis, P. A., Gnant, M., Perrone, F., Regan, M. M., Berry, R., Boddington, C., Clarke, M., Davies, C., Davies, L., Duane, F. & 31 others, Evans, V., Gay, J., Gettins, L., Godwin, J., James, S., Liu, H., MacKinnon, E., Mannu, G., McHugh, T., Morris, P., Read, S., Straiton, E., Jakesz, R., Fesl, C., Pagani, O., Gelber, R., De Laurentiis, M., De Placido, S., Gallo, C., Albain, K., Anderson, S., Arriagada, R., Bartlett, J., Bergsten-Nordström, E., Bliss, J., Brain, E., Carey, L., Coleman, R., Cuzick, J., Ejlertsen, Bent Laursen & Early Breast Cancer Trialists' Collaborative Group (EBCTCG), E. B. C. T. C. G. (., 2022, In: The Lancet Oncology. 23, 3, p. 382-392 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  16. Published

    Cardiotoxicity in relation to treatment with aromatase inhibitors in breast cancer

    Lund, Marie & Ejlertsen, Bent Laursen, 2022, In: Adverse Drug Reaction Bulletin. 332, 1, p. 1287-1290 4 p.

    Research output: Contribution to journalReviewResearchpeer-review

  17. Published

    First-Line Treatment of HER2-Positive Metastatic Breast Cancer With Dual Blockade Including Biosimilar Trastuzumab (SB3): Population-Based Real-World Data From the DBCG

    Celik, A., Berg, T., Nielsen, L. B., Jensen, M., Ejlertsen, Bent Laursen, Knoop, A. & Andersson, M., 2022, In: Breast Cancer: Basic and Clinical Research. 16, 6 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  18. Published

    Mortality After Late Breast Cancer Recurrence in Denmark

    Pedersen, R. N., Mellemkjær, L., Ejlertsen, Bent Laursen, Nørgaard, M. & Cronin-Fenton, D. P., 2022, In: Journal of Clinical Oncology. 40, 13, p. 1450-1463 14 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  19. Published

    Neither Tumor-Infiltrating Lymphocytes nor Cytotoxic T Cells Predict Enhanced Benefit from Chemotherapy in the DBCG77B Phase III Clinical Trial

    Shenasa, E., Stovgaard, Elisabeth Ida Specht, Jensen, M. B., Asleh, K., Riaz, N., Gao, D., Leung, S., Ejlertsen, Bent Laursen, Lænkholm, Anne-Vibeke & Nielsen, T. O., 2022, In: Cancers. 14, 15, 14 p., 3808.

    Research output: Contribution to journalJournal articleResearchpeer-review

  20. Published

    Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark

    Hjorth, C. F., Damkier, P., Stage, T. B., Feddersen, S., Hamilton-Dutoit, S., Rørth, M., Ejlertsen, Bent Laursen, Lash, T. L., Ahern, T. P., Sørensen, H. T. & Cronin-Fenton, D., 2022, In: Breast Cancer Research and Treatment. 194, 2, p. 353-363 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  21. Published

    Survival in Women Diagnosed With Breast Cancer During Pregnancy

    Viuff, J. H., Greiber, I. K., Karlsen, M. A., Storgaard, L., Kroman, Niels Thorndahl, Jensen, M. B., Eibye, S., Hjortshøj, C. S., Ejlertsen, Bent Laursen, Winther, J. F., Kjær, Susanne Krüger & Mellemkjær, L., 2022, In: Clinical Breast Cancer. 22, 4, p. e517-e525 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  22. Published

    Systemic or Vaginal Hormone Therapy After Early Breast Cancer: A Danish Observational Cohort Study

    Cold, S., Cold, F., Jensen, M. B., Cronin-Fenton, D., Christiansen, P. & Ejlertsen, Bent Laursen, 2022, In: Journal of the National Cancer Institute. 114, 10, p. 1347-1354 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  23. Published

    Use of beta-blockers and risk of contralateral breast cancer

    Gottschau, M., Bens, A., Friis, S., Cronin-Fenton, D., Aalborg, G. L., Jensen, M., Ejlertsen, Bent Laursen, Kroman, Niels Thorndahl & Mellemkjær, L., 2022, In: International Journal of Cancer. 150, 10, p. 1619-1626

    Research output: Contribution to journalJournal articleResearchpeer-review

  24. 2021
  25. Published

    Clinical implications of intrinsic molecular subtypes of breast cancer for sentinel node status

    Rossing, M., Pedersen, C. B., Tvedskov, Tove Filtenborg, Vejborg, I., Talman, M. L., Olsen, L. R., Kroman, Niels Thorndahl, Nielsen, Finn Cilius, Jensen, M. B. & Ejlertsen, Bent Laursen, Dec 2021, In: Scientific Reports. 11, 1, 12 p., 2259.

    Research output: Contribution to journalJournal articleResearchpeer-review

  26. Published

    Trastuzumab for early-stage, HER2-positive breast cancer: a meta-analysis of 13 864 women in seven randomised trials

    Early Breast Cancer Trialists’ Collaborative group (EBCTCG), E. B. C. T. C. G. (., Aug 2021, In: The Lancet Oncology. 22, 8, p. 1139-1150 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  27. Published

    Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer

    Jørgensen, N., Hviid, Thomas Vauvert F., Nielsen, L. B., Sønderstrup, I. M. H., Eriksen, J. O., Ejlertsen, Bent Laursen, Gerdes, Anne-Marie Axø, Kruse, T. A., Thomassen, M., Jensen, M. & Lænkholm, Anne-Vibeke, Aug 2021, In: British Journal of Cancer. 125, p. 1388–1398

    Research output: Contribution to journalJournal articleResearchpeer-review

  28. Published

    Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial

    ExteNET Study Group, E. S. G., Feb 2021, In: Clinical Breast Cancer. 21, 1, p. 80-91.e7 19 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  29. Published

    A careful reassessment of anthracycline use in curable breast cancer

    Hurvitz, S. A., McAndrew, N. P., Bardia, A., Press, M. F., Pegram, M., Crown, J. P., Fasching, P. A., Ejlertsen, Bent Laursen, Yang, E. H., Glaspy, J. A. & Slamon, D. J., 2021, In: npj Breast Cancer. 7, 1, 25 p., 134.

    Research output: Contribution to journalReviewResearchpeer-review

Previous 1 2 3 4 Next

ID: 10818876